{
  "id": 11509686,
  "title": "USA: „Am schnellsten wachsender Markt“ – Bayer investiert 2,2 Milliarden Dollar in neues US-Werk",
  "url": "https://urgent.news/2026/10/02/usa-am-schnellsten-wachsender-markt-bayer-investiert-2-2-milliarden",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-02T19:10:06.000Z",
  "source": {
    "name": "Handelsblatt",
    "slug": "handelsblatt",
    "url": "https://www.handelsblatt.com/unternehmen/industrie/usa-bayer-investiert-22-milliarden-dollar-in-neues-us-werk/100259162.html"
  },
  "original_language": "en",
  "account": "Bayer, the German pharmaceutical and agricultural corporation, has announced plans to invest $2.2 billion in constructing a new pharmaceutical factory in New Albany, Ohio, United States. The company revealed this information on Friday night. Initially, the facility will focus on producing cancer, heart disease, and kidney medications on a campus, creating approximately 600 new jobs. This project represents one of Bayer's largest individual investments in a U.S. pharmaceutical plant. The site will also serve as part of a new cooperation network in the U.S., linking production with academic research, according to a statement. Bayer's U.S. chief, Sebastian Guth, emphasized that the expansion is another significant step to expand the company's pharmaceutical business and serve the demand of customers and patients in the U.S. and beyond. He highlighted that the U.S. is the fastest-growing pharmaceutical market for Bayer. The company already generates about 35% of its revenue in North America from prescription drugs. Guth stated to Handelsblatt last December that the U.S. drug sales are expected to at least double by the end of the decade. Over the past five years, Bayer has reportedly spent over seven billion dollars in the U.S. on research, development, and production for its pharmaceutical division.",
  "summary": "In Ohio will der Pharmakonzern künftig Krebs-, Herz- und Nierenmedikamente herstellen. Bayer stärkt damit sein US-Geschäft – mitten in Trumps Kampf gegen hohe Arzneimittelpreise.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 4,
    "also_reported_by": [
      {
        "outlet": "NZZ Wirtschaft",
        "title": "200 Milliarden Dollar: Donald Trump kündigt hohe Investitionen Südkoreas an",
        "url": "https://urgent.news/2026/10/01/200-milliarden-dollar-donald-trump-kundigt-hohe-investitionen",
        "published": "2026-10-01T10:03:25.000Z"
      },
      {
        "outlet": "Handelsblatt",
        "title": "US-Zölle: Trump kündigt Milliardeninvestitionen an – Südkorea widerspricht doch",
        "url": "https://urgent.news/2026/10/01/us-zolle-trump-kundigt-milliardeninvestitionen-an-sudkorea",
        "published": "2026-10-01T11:01:33.000Z"
      },
      {
        "outlet": "Le Monde Economie",
        "title": "Fuels: Donald Trump says he 'could' ask Europeans to tap into their diesel reserves to bring prices down",
        "url": "https://urgent.news/2026/10/01/carburants-donald-trump-dit-quil-pourrait-demander-aux-europeens-de",
        "published": "2026-10-01T22:00:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}